- August 5, 2025: Q2 earnings beat expectations with $1.36 EPS (56% growth!) but the stock dipped due to concerns about Philips partnership
- May 6, 2025: Q1 results showed “double-digit revenue growth” but leadership transition created uncertainty
- February 2025: New CEO Katie Szyman joined, bringing fresh energy but also transition risks
How to Buy Masimo Corporation (MASI) Shares - Investment in Masimo Corporation (MASI) Stock
Updated on 25 Aug 2025
Thinking about investing in cutting-edge medical technology? Masimo Corporation represents the future of patient monitoring with revolutionary non-invasive technologies that save lives daily. This isn't just another stock—it's a chance to own a piece of healthcare innovation that impacts over 200 million patients annually worldwide.
Article navigation
- 📈 Masimo Stock Performance: Current Status and Critical Dates
- 📊 6-Month Price Journey: Rollercoaster with Purpose
- 🔮 Price Forecast: 2025-2030 Growth Trajectory
- ⚠️ Risk Assessment: Know Before You Buy
- 🎯 Beginner Trader Action Plan Today
- ✅ How to Buy Masimo Corporation (MASI) Shares – Step by Step
- 💡 Why Pocket Option Makes Sense for Medical Tech Investing
- 🏥 Masimo in 2025: Healthcare Innovation Leader
📈 Masimo Stock Performance: Current Status and Critical Dates
As of August 25, 2025, Masimo Corporation (MASI) is trading at $148.63 on the NASDAQ exchange. But here’s what really matters for your investment timing…
Mark November 4, 2025 on your calendar—this is earnings day! Historically, Masimo’s earnings reports create significant price movements. Looking back at recent history:
The pattern shows that while Masimo consistently delivers strong fundamentals, external factors and partnership concerns can create temporary volatility. Smart investors use these dips as buying opportunities.
📊 6-Month Price Journey: Rollercoaster with Purpose
From February to August 2025, MASI has taken investors on quite a ride:
| Month | Price Range | Key Events |
|---|---|---|
| February | $130-140 | New CEO appointment, market uncertainty |
| March | $145-155 | Leadership stabilization, positive guidance |
| April | $150-165 | Q1 earnings anticipation build-up |
| May | $140-150 | Post-earnings adjustment, partnership concerns |
| June | $135-145 | Summer slowdown, tariff concerns |
| July | $140-150 | Recovery phase, cost mitigation success |
| August | $145-150 | Q2 earnings, improved guidance |
Overall trend: Despite some volatility, the stock has maintained relative stability around the $145-150 range, showing resilience amid leadership changes and external challenges.
🔮 Price Forecast: 2025-2030 Growth Trajectory
Based on current analyst projections and company fundamentals:
2025 Year-End: $160-175 (8-18% upside from current levels) → BUY
The improved EPS guidance to $5.20-$5.45 and successful tariff mitigation create strong tailwinds
2026: $180-200
Healthcare sector recovery and expanded FDA clearances should drive growth
2028: $220-250
Market leadership in pulse oximetry and remote monitoring expansion
2030: $280-320
Global healthcare digitization and aging population trends benefit medical tech
⚠️ Risk Assessment: Know Before You Buy
Potential Risks:
- Partnership dependency: The Philips relationship uncertainty weighs on investor sentiment
- Regulatory changes: FDA approval processes can delay product launches
- Tariff impacts: While mitigated, global trade tensions remain a concern
- Leadership transition: New CEO Katie Szyman is still proving her strategy
Positive Signals for 2025:
- ✅ Strong earnings growth: 56% EPS growth in Q2 2025
- ✅ Improved guidance: Raised EPS forecast from $4.80-$5.15 to $5.20-$5.45
- ✅ Strategic focus: Sold non-core audio business to concentrate on healthcare
- ✅ Innovation pipeline: Recent FDA clearances for expanded monitoring capabilities
- ✅ Market position: #1 pulse oximetry technology at all top 10 US hospitals
🎯 Beginner Trader Action Plan Today
Serious recommendations:
- Start small: Begin with a position size you’re comfortable with—even 1-2 shares gets you in the game
- Dollar-cost average: Consider buying in increments around earnings dates when volatility often creates opportunities
- Set price alerts: Monitor the $140-145 range for potential entry points
Humorous trader wisdom: “Trading MASI is like monitoring a patient—you need to watch the vital signs (earnings), ignore the noise (daily fluctuations), and trust the technology (their amazing SET platform). Just don’t try to read the stock chart while wearing their pulse oximeter—it might give you false readings about your own heart rate!”
✅ How to Buy Masimo Corporation (MASI) Shares – Step by Step
| Step | Action | Why This Matters |
|---|---|---|
| 1 | Choose your platform | Select a broker that offers NASDAQ access with reasonable fees |
| 2 | Open and fund account | Start with an amount you can afford to potentially lose while learning |
| 3 | Research current price | Check real-time quotes at market open (9:30 AM EST) |
| 4 | Place limit order | Set your maximum purchase price to avoid overpaying during volatility |
| 5 | Monitor your position | Track earnings dates and industry news that could impact value |
💡 Why Pocket Option Makes Sense for Medical Tech Investing
For investors interested in companies like Masimo, Pocket Option offers unique advantages:
Minimum deposit just $5—perfect for testing strategies with medical technology stocks without significant risk. The platform’s 1-minute KYC process means you can start trading quickly when opportunities arise, crucial for catching post-earnings movements. With hundreds of withdrawal methods, you can easily access profits from successful healthcare investments.
The ability to trade with small amounts allows you to build positions gradually in innovative companies like Masimo, which is particularly valuable when building a diversified portfolio across the growing healthcare technology sector.
🏥 Masimo in 2025: Healthcare Innovation Leader
Masimo Corporation stands at the forefront of medical technology with their revolutionary Signal Extraction Technology (SET) that accurately monitors patients even during movement or low blood flow conditions. What makes them special? Their technology is used in all top 10 US hospitals and monitors over 200 million patients annually.
The company recently made a strategic pivot by selling their consumer audio business to focus entirely on healthcare innovation. Under new CEO Katie Szyman, they’re driving toward 8-11% revenue growth in 2025 while successfully mitigating tariff impacts that previously concerned investors.
Interesting Fact for 2025: Masimo’s SET technology is so accurate that it shows no clinically significant differences between patients with dark and light skin tones—addressing a critical healthcare equity issue that has plagued traditional pulse oximeters for decades.
FAQ
What does Masimo Corporation actually do?
Masimo develops non-invasive patient monitoring technologies, primarily focused on pulse oximetry that works accurately during patient movement and low blood flow conditions. Their products are used in hospitals worldwide.
Why did the stock price drop after good earnings in August 2025?
Despite beating earnings expectations, concerns about their partnership with Philips created investor uncertainty that temporarily overshadowed the strong financial results.
Is now a good time to buy MASI stock?
With the current price around $148.63 and analyst targets up to $210, many believe there's significant upside potential, especially given the improved earnings guidance.
What makes Masimo different from other medical device companies?
Their SET technology provides dramatically more accurate readings during challenging conditions, and they've solved skin tone accuracy issues that affect traditional devices.
How often does Masimo pay dividends?
Masimo does not currently pay dividends, preferring to reinvest profits into research and development to maintain their technological leadership position.
Signals
Sign up for more like this
Customize your newsfeed with content you're actually interested in — get up-to-date personalized newsletter in your inbox.
Your comment
Comments are pre-moderated to ensure they comply with our blog guidelines.